Medquick Pharmaceutical Private Limited
About Medquick Pharmaceutical Private Limited
Data last updated:
Medquick Pharmaceutical Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U85110MP2019PTC048824.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sandeep Agarwal and Kapil Bansal.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at E – 301 Greenvalley Apartment Kanadiya Road, Indore, Madhya Pradesh, India – 452016.
As per the financials filed for FY 2021, the company reported a revenue of ₹8.88 Lakh, a decline of 51% compared to the previous year. For the same year it recorded a net loss of ₹24,052 (net margin -2.7%) and EBITDA of -₹4,982 (EBITDA margin -0.6%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressE – 301 Greenvalley Apartment Kanadiya Road, Indore, Madhya Pradesh, India – 452016
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medquick Pharmaceutical Private Limited
The main business activity of Medquick Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medquick Pharmaceutical Private Limited FY 2021 filings available
Medquick Pharmaceutical Private Limited reported revenue of ₹8.88 Lakh (down 51% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Medquick Pharmaceutical Private Limited
Revenue fell 51% in the latest year. EBITDA rose 99% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Medquick Pharmaceutical Private Limited
| Metrics | FY 2020-21 | FY 2019-20 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹4,982 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹24,052 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Medquick Pharmaceutical Private Limited
| Metrics | FY 2020-21 | FY 2019-20 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -0.6% | •••• |
| Net Profit Margin | -2.7% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medquick Pharmaceutical are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medquick Pharmaceutical Private Limited
Medquick Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Laxmidhan Vyapaar Private Limited | ₹8.89 Lakh (FY 2024) | •••• | •••• | -34.0% | •••• | Siliguri, West Bengal, India |
| Ur Decor Private Limited | ₹8.89 Lakh (FY 2023) | •••• | •••• | •••• | Jaipur, Rajasthan, India | |
| Dove Marketing Private Limited | ₹8.88 Lakh (FY 2024) | •••• | •••• | 29.0% | •••• | Delhi, India |
| Jaikaali Tracom Private Limited | ₹8.88 Lakh (FY 2019) | •••• | •••• | -5.0% | •••• | Salkia, West Bengal, India |
| Avenue Traders Pvt. Ltd. | ₹8.88 Lakh (FY 2024) | •••• | •••• | 49.0% | •••• | Howrah, West Bengal, India |
| Medquick Pharmaceutical Private Limited this company | ₹8.88 Lakh (FY 2021) | •••• | •••• | -51.0% | •••• | Indore, Madhya Pradesh, India |
| Horizon Manufacturing Private Limited | ₹8.88 Lakh (FY 2023) | •••• | •••• | -78.0% | •••• | Mumbai, Maharashtra, India |
| Nesta Sales Agency Private Limited | ₹8.88 Lakh (FY 2016) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Medicostar Pharmaceuticals Private Limited | ₹8.88 Lakh (FY 2024) | •••• | •••• | 108.0% | •••• | Surat, Gujarat, India |
| Himalayan Sweven Private Limited | ₹8.88 Lakh (FY 2025) | •••• | •••• | 570.0% | •••• | Patna, Bihar, India |
| Markstone Fashions and Retails Private Limited | ₹8.88 Lakh (FY 2025) | •••• | •••• | -53.0% | •••• | Ernakulam, Kerala, India |
Peers are the five companies nearest above and the five nearest below Medquick Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Medquick Pharmaceutical Private Limited
Medquick Pharmaceutical has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Agarwal | Director | 07 Jun 2019 | 7 Years 4 Months | Current |
| Kapil Bansal | Director | 07 Jun 2019 | 7 Years 4 Months | Current |
| Sumit Bansal | Director | 07 Jun 2019 | 7 Years 4 Months | Current |
| Rajiv Bansal | Director | 07 Jun 2019 | 7 Years 4 Months | Current |
| Sharad Kumar Mangal Also directs: S. G. Agricrop Private Limited, Abhijeet Agrilink Private Limited | Director | 07 Jun 2019 | 7 Years 4 Months | Current |
Charges & Borrowings of Medquick Pharmaceutical Private Limited
Medquick Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Medquick Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Medquick Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medquick Pharmaceutical Private Limited
Medquick Pharmaceutical Private Limited has 5 board changes on record since 2019: 5 appointments. The latest: Kapil Bansal was appointed as Director on 07 Jun 2019.
Credit Ratings, Litigation & Regulatory Alerts for Medquick Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medquick Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medquick Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medquick Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medquick Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medquick Pharmaceutical Private Limited
Medquick Pharmaceutical is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 June 2019 (7+ years old) and is registered under CIN U85110MP2019PTC048824.
Medquick Pharmaceutical reported revenue of ₹8.88 Lakh for FY 2021 (down 51% YoY).
Medquick Pharmaceutical has 5 current directors:
- Sandeep Agarwal - Director
- Kapil Bansal - Director
- Sumit Bansal - Director
- Rajiv Bansal - Director
- Sharad Kumar Mangal - Director
Medquick Pharmaceutical reported a net loss of ₹24,052 (net margin -2.7%) and EBITDA of -₹4,982 (EBITDA margin -0.6%) for FY 2021, as per its filed financial statements.
The CIN (Corporate Identification Number) of Medquick Pharmaceutical is U85110MP2019PTC048824. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medquick Pharmaceutical was incorporated on 07 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Medquick Pharmaceutical by revenue are Laxmidhan Vyapaar Private Limited, Ur Decor Private Limited, Dove Marketing Private Limited, Jaikaali Tracom Private Limited, Avenue Traders Pvt. Ltd. and 5 more, all in the same principal business activity (Wholesale Trading).
Kapil Bansal was appointed as Director on 07 Jun 2019. Rajiv Bansal was appointed as Director on 07 Jun 2019. Sandeep Agarwal was appointed as Director on 07 Jun 2019. Medquick Pharmaceutical has 5 board changes on record in total.
The registered office of Medquick Pharmaceutical is at E – 301 Greenvalley Apartment Kanadiya Road, Indore, Madhya Pradesh, India – 452016.
Medquick Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Medquick Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.